To evaluate whether OXPHOS inhibition could efficiently target MM cells in vivo, we established a MM xenograft model by transplanting ILF2 ASO–resistant GFP+Luc+ JJN3 cells into NSG mice. This evidence concerns the gene ILF2 and Miyoshi myopathy.